FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Michael A. Singer, MD, discusses phase 3 data from the PALADIN study. Over time, patients with diabetic macular edema treated with the Iluvien implant (fluocinolone acetonide intravitreal implant 0.19 mg, Alimera Sciences) had less of an IOP increase than previous studies and better vision, Singer said.